Addition of Adjuvant Tamoxifen to Cyclophosphamide, Methotrexate and 5-Fluorouracil for Premenopausal Women with Oestrogen Receptor-Positive Breast Cancer

To study the value of adjuvant tamoxifen (TAM) in premenopausal women with oestrogen receptor (ER)-positive breast cancer who received adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) polychemotherapy. Methods: Four hundred and two premenopausal ER-positive breast cancer patients who...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: He-Cheng Li, Xian-Feng Wen, Yi-Feng Hou, Kun-Wei Shen, Jong Wu, Jing-Song Lu, Zhen-Zhou Shen, Zhi-Ming Shao
Format: Artykuł
Język:English
Wydane: Elsevier 2003-07-01
Seria:Asian Journal of Surgery
Dostęp online:http://www.sciencedirect.com/science/article/pii/S1015958409603778